• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reducing the gap of chronic kidney disease in low- and middle-income countries: what is missing?

作者信息

López Darío Sebastián, Hernández Vargas Juliana Alexandra, Urina-Jassir Manuel, Urina-Triana Miguel, Franco Oscar H

机构信息

School of Health and Sport Sciences, MSc Program in Epidemiology, Fundación Universitaria del Área Andina, Bogotá, Colombia.

Department of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.

出版信息

Lancet Reg Health Am. 2023 Oct 31;28:100625. doi: 10.1016/j.lana.2023.100625. eCollection 2023 Dec.

DOI:10.1016/j.lana.2023.100625
PMID:37969876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10638012/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2aa/10638012/fc67ac6b2ec1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2aa/10638012/fc67ac6b2ec1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2aa/10638012/fc67ac6b2ec1/gr1.jpg

相似文献

1
Reducing the gap of chronic kidney disease in low- and middle-income countries: what is missing?缩小低收入和中等收入国家慢性肾脏病的差距：缺失了什么？
Lancet Reg Health Am. 2023 Oct 31;28:100625. doi: 10.1016/j.lana.2023.100625. eCollection 2023 Dec.
2
Chronic kidney disease in low-income to middle-income countries: the case for increased screening.低收入至中等收入国家的慢性肾脏病：加强筛查的理由
BMJ Glob Health. 2017 May 29;2(2):e000256. doi: 10.1136/bmjgh-2016-000256. eCollection 2017.
3
Missing in action: international aid agencies in poor countries to fight chronic disease.不见踪影：国际援助机构在贫困国家抗击慢性病的情况
Health Aff (Millwood). 2009 Jan-Feb;28(1):202-5. doi: 10.1377/hlthaff.28.1.202.
4
Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries.精神分裂症障碍的服务提供情况、利用情况和治疗差距：50 个低收入和中等收入国家的调查。
Bull World Health Organ. 2012 Jan 1;90(1):47-54, 54A-54B. doi: 10.2471/BLT.11.089284. Epub 2011 Oct 31.
5
Screening for Kidney Disease in Low- and Middle-Income Countries.中低收入国家的肾脏疾病筛查。
Semin Nephrol. 2022 Sep;42(5):151315. doi: 10.1016/j.semnephrol.2023.151315. Epub 2023 Mar 29.
6
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.世界六个地区的慢性肾脏病和心血管风险（ISN-KDDC）：一项横断面研究。
Lancet Glob Health. 2016 May;4(5):e307-19. doi: 10.1016/S2214-109X(16)00071-1.
7
The Impact of Low Socioeconomic Status on Progression of Chronic Kidney Disease in Low- and Lower Middle-Income Countries.低社会经济地位对中低收入国家慢性肾脏病进展的影响。
Semin Nephrol. 2022 Sep;42(5):151338. doi: 10.1016/j.semnephrol.2023.151338. Epub 2023 Mar 24.
8
Gender gap matters in maternal mortality in low and lower-middle-income countries: A study of the global Gender Gap Index.在中低收入国家，母婴死亡率的性别差距问题值得关注：对全球性别差距指数的研究。
Glob Public Health. 2017 Sep;12(9):1065-1076. doi: 10.1080/17441692.2016.1162318. Epub 2016 Mar 28.
9
Acute kidney injury in low- and middle-income countries: investigations, management and prevention.低收入和中等收入国家的急性肾损伤：调查、管理与预防
Paediatr Int Child Health. 2017 Nov;37(4):269-272. doi: 10.1080/20469047.2017.1386816.
10
COVID-19 and Kidney Disease: Progress in Health Inequity From Low-Income Settings.COVID-19 与肾脏疾病：低收入国家健康不平等的进展。
Semin Nephrol. 2022 Sep;42(5):151318. doi: 10.1016/j.semnephrol.2023.151318. Epub 2023 Jan 16.

引用本文的文献

1
Global burden and trends of high BMI-attributable chronic kidney disease: a comprehensive analysis from 1990 to 2021 and projections to 2035.高体重指数所致慢性肾脏病的全球负担及趋势：1990年至2021年的综合分析及到2035年的预测
Front Nutr. 2025 Jul 22;12:1611227. doi: 10.3389/fnut.2025.1611227. eCollection 2025.
2
Kidney health outcomes of hypertensive disorders of pregnancy.妊娠期高血压疾病的肾脏健康结局
Nat Rev Nephrol. 2025 Jul 18. doi: 10.1038/s41581-025-00977-8.
3
Rethinking Models of Chronic Kidney Disease Care: A Narrative Review.

本文引用的文献

1
Empagliflozin in Patients with Chronic Kidney Disease.恩格列净在慢性肾脏病患者中的应用。
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
2
Patient Awareness of CKD: A Systematic Review and Meta-analysis of Patient-Oriented Questions and Study Setting.慢性肾脏病患者的知晓情况：针对患者导向性问题及研究背景的系统评价与荟萃分析
Kidney Med. 2021 Jun 1;3(4):576-585.e1. doi: 10.1016/j.xkme.2021.03.014. eCollection 2021 Jul-Aug.
3
Screening and early detection of chronic kidney disease at primary healthcare.
重新审视慢性肾脏病护理模式：一项叙述性综述。
Kidney Blood Press Res. 2025;50(1):433-441. doi: 10.1159/000546562. Epub 2025 May 23.
4
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.慢性肾脏病多种治疗时代未来肾脏保护试验的设计考量
Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i70-i79. doi: 10.1093/ndt/gfae210.
5
Factors associated with chronic kidney disease knowledge and preventive practices: An analytical cross-sectional study among patients with hypertension at Amana Regional Referral Hospital in Dar es Salaam, Tanzania.与慢性肾脏病知识及预防措施相关的因素：坦桑尼亚达累斯萨拉姆阿马纳地区转诊医院高血压患者的一项分析性横断面研究
PLoS One. 2025 Jan 8;20(1):e0317257. doi: 10.1371/journal.pone.0317257. eCollection 2025.
6
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.醛固酮合酶抑制剂维卡司他（BI 690517）改善慢性肾脏病心肾结局的潜力：EASi-KIDNEY试验的理论依据
Nephrol Dial Transplant. 2025 May 30;40(6):1175-1186. doi: 10.1093/ndt/gfae263.
在基层医疗保健中进行慢性肾脏病的筛查和早期检测。
Clin Exp Hypertens. 2021 Jul 4;43(5):416-418. doi: 10.1080/10641963.2021.1896726. Epub 2021 Mar 17.
4
Framework for establishing integrated kidney care programs in low- and middle-income countries.在低收入和中等收入国家建立综合肾脏护理项目的框架。
Kidney Int Suppl (2011). 2020 Mar;10(1):e19-e23. doi: 10.1016/j.kisu.2019.11.002. Epub 2020 Feb 19.
5
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担，1990-2017 年：2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
6
Burden, access and disparities in kidney disease.肾病的负担、可及性与差异
Clin Kidney J. 2019 Feb 18;12(2):160-166. doi: 10.1093/ckj/sfy128. eCollection 2019 Apr.
7
Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development.全球肾脏疾病健康信息系统的覆盖情况：可用性、挑战与发展机遇
Kidney Int Suppl (2011). 2018 Feb;8(2):74-81. doi: 10.1016/j.kisu.2017.10.011. Epub 2018 Jan 19.
8
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率：2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.
9
Chronic kidney disease care models in low- and middle-income countries: a systematic review.低收入和中等收入国家的慢性肾脏病护理模式：一项系统综述
BMJ Glob Health. 2018 Apr 1;3(2):e000728. doi: 10.1136/bmjgh-2018-000728. eCollection 2018.
10
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.全球慢性肾脏病患病率——一项系统评价与荟萃分析
PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016.